{"prompt": "['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 11 of 115', '2. Glossary', 'Table 1: Glossary', 'Term', 'Definition', 'AE', 'Adverse event', 'AF', 'Atrial fibrillation', 'AAD', 'Antiarrhythmic drug', 'ACC', 'American College of Cardiology', 'ACT', 'Activated clotting time', 'ADE', 'Adverse device effect', 'AFL', 'Atrial flutter', 'AHA', 'America Heart Association', 'AT', 'Atrial tachycardia', 'AFEQT', 'Atrial fibrillation effect on quality-of-life', 'questionnaire', 'BMI', 'Body mass index', 'C', 'Celsius', 'CT', 'Computed tomography', 'CV', 'Curriculum vitae', 'CEC', 'Clinical Events Committee', 'CFE', 'Complex fractionated electrograms', 'CFR', 'Code of Federal Regulations', 'CIP', 'Clinical investigation plan', 'CRF', 'Case report form', 'CTA', 'Clinical trial agreement', 'DC', 'Direct current', 'Version 4, 10NOVO016', 'Confidential']['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 12 of 115', 'DD', 'Device deficiency', 'e.g.', 'For example', 'ECG', 'Electrocardiogram', 'ECAS', 'European Cardiac Arrhythmia Society', 'ECRF', 'Electronic case report form', 'EHRA', 'European Heart Rhythm Association', 'F', 'Fahrenheit', 'FD', 'Financial disclosure', 'FAL', 'Foreseeable adverse event list', 'FDA', 'Food and Drug Administration', 'FDAAA', 'Food and Drug Administration Amendments Act', 'GCP', 'Good clinical practice', 'GEE', 'Generalized estimating equation', 'HR', 'Hazard ration', 'HRS', 'Heart Rhythm Society', 'HOMI', 'Head of medical institution', 'ID', 'Identification', 'IDE', 'Investigational device exemption', 'Inc', 'Incorporated', 'IRB', 'Institutional review board', 'ISO', 'International Organization for Standardization', 'ICMJE', 'International Committee of Medical Journal Editors', 'LAD', 'Left atrial diameter', 'LVEF', 'Left ventricular ejection fraction', 'MDD', 'Medical device directive', 'Version 4, 10NOVO016', 'Confidential']['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 13 of 115', 'MEC', 'Medical ethics committee', 'MHLW', 'Ministry of Health, Labour and Welfare', 'MedDRA', 'Medical Dictionary for Regulatory Activities', 'NOAC', 'Novel oral anticoagulant', 'NYHA', 'New York Heart Association', 'N2O', 'Nitrous Oxide', 'OPC', 'Objective performance criteria', 'PV', 'Pulmonary vein', 'PAF', 'Paroxysmal atrial fibrillation', 'PCI', 'Percutaneous coronary intervention', 'PIC', 'Patient informed consent', 'PVI', 'Pulmonary vein isolation', 'PTCA', 'Percutaneous transluminal coronary angioplasty', 'PMDA', 'Pharmaceuticals and Medical Devices Agency', 'PMA-S', 'Premarket Approval Supplement', 'RF', 'Radiofrequency', 'RI', 'Right inferior', 'RS', 'Right superior', 'SD', 'Standard deviation', 'SF', 'Short form', 'SAE', 'Serious adverse event', 'SAP', 'Statistical analysis plan', 'SCD', 'Sudden cardiac death', 'SADE', 'Serious adverse device effect', 'TEE', 'Transesophageal echocardiogram', 'Version 4, 10NOVO016', 'Confidential']\n\n###\n\n", "completion": "END"}